Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01588457 · ClinicalTrials.gov registry record · Phase 4
Sequential Multiple Assignment Treatment for Bipolar Disorder
A Phase 4 study, sponsored by The University of Texas Health Science Center at San Antonio.
- Completed
- Registry status
- Phase 4
- Development phase
- 112
- Enrollment target
NCT01588457 is a Phase 4 study that has completed, run by The University of Texas Health Science Center at San Antonio. The registered enrollment target is 112 participants.
The verdict
NCT01588457, a Phase 4 study, has completed, sponsored by The University of Texas Health Science Center at San Antonio.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 112 participants
- Enrollment target
Study Summary
The purpose of this study is to compare which of the two mood stabilizers (drugs that help to steady/stabilize mood in patients with bipolar disorder (BD)), lithium and divalproex, is more effective in patients with bipolar disorder over 26 weeks. The study will also compare if lithium or divalproex used alone versus lithium or divalproex used with quetiapine versus lithium or divalproex used with lamotrigine is more effective when symptoms of depression develop.
Interventions
- DRUG Lamotrigine
- DRUG Lithium
- DRUG Quetiapine
- DRUG Divalproex
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 112 participants |
| Start Date | 2011-06 |
| Est. Completion | 2016-12 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01588457
The ClinicalTrials.gov registry entry for NCT01588457 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 112 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is The University of Texas Health Science Center at San Antonio, which has 378 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which Lamotrigine is the first listed.
NCT01588457 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01588457 about?
NCT01588457 is a clinical study titled "Sequential Multiple Assignment Treatment for Bipolar Disorder". The purpose of this study is to compare which of the two mood stabilizers (drugs that help to steady/stabilize mood in patients with bipolar disorder (BD)), lithium and divalproex, is more effective in patients with bipolar disorder over 26 weeks. The study will also compare if lithium or divalproex...
What is the current status of trial NCT01588457?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 112 participants. The study started on 2011-06. Estimated completion is 2016-12.
What interventions are being tested in trial NCT01588457?
The interventions under investigation include: Lamotrigine (DRUG), Lithium (DRUG), Quetiapine (DRUG), Divalproex (DRUG).
Who is sponsoring clinical trial NCT01588457?
This trial is sponsored by The University of Texas Health Science Center at San Antonio, which has 378 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.